Drug
Aro Sod1
Aro Sod1: highest development phase Phase 1, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-SOD1 Injection NCT05949294 | Phase 1 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Aro Sod1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.